Videos & Webinars


Introducing Decision-Making Under Uncertainty to Medical Research: Designing More Efficient and More Accurate Clinical Trials.  Don Berry's presentation at the Simons Institute for the Theory of Computing at University of California Berkeley.

Berry Consultants released a new video series on adaptive designs during 2015-2016.  The complete video library can be found on Berry Consultants You Tube Channel.   Here are some of the videos released:

-Top Ten Misconceptions About Adaptive Trials (Berry Consultants Team)
-What Clinicians Should Know About Adaptive Clinical Trials (Dr. Roger Lewis)
-How to Design an Adaptive Trial - Lessons Learned So Far (Dr. Scott Berry)
-The Adaptive Platform Trial - The Statistical Efficiencies (Dr. Scott Berry)
-I-Spy 2 and Other Platform Trials (Dr. Don Berry)
-The Use of Historical Information in Clinical Trials (Dr. Kert Viele)
-Driving With Your Eyes Open (Dr. Jason Connor)
-In Silico Cinical Trial Design (Dr. Scott Berry)
-DSMBs for Adaptive Trials (Dr. Roger Lewis)
-The Value of Biomarkers (Dr. Jason Connor)
-NCAA Football and the Ebola Pandemic (Dr. Scott Berry)
-Multiplicities, Big Data = Big Problems, Irreproducible Research, & The Umbrella Man (Dr. Don Berry)
-The Billion Dollar Statistical Concept (Dr. Scott Berry)
-RE-ADAPT: Do Bayesian Adaptive Trials Offer Advantages for Comparative Effectiveness Research?
(Dr. Jason Connor)
-Rare Diseases and Slow Decline: Can Thomas Bayes Help? (Dr. Scott Berry)

The Lowdown on Adaptive Clinical Trials with Don Berry interviews Don Berry through a podcast sponsored by the National Biomarker Development Alliance (NBDA) on July 28, 2014 that discusses a promising new approach to clinical trials.

President's Council of Advisors on Science and Technology (PCAST)
Don Berry presents as part of a panel of Researchers on the topic of "Improving Scientific Reproducibility in an Age of International Competition and Big Data I" at the PCAST Public Meeting on January 31, 2014.

The Design of Complex Adaptive Trials,
Scott Berry presents at the "Transforming Drug Development - Delivering Innovation and Efficiency through Adaptive Clinical Trials" conference that was co-sponsored by Berry Consultants.

Roger Lewis:  Overview of Adaptive Designs,
William Meurer:  Adaptive Designs - Emergency Care Perspective,
Scott Berry:  ICECAP - Adaptive Design for Optimizing Duration of Treatment,
Scott Berry and Roger Lewis join William Meurer of University of Michigan to create an Educational Webinar Series on "Adaptive Clinical Trials" for the Clinical & Translational Science Awards Consortium (CTSA).  The CTSA Consortium is funded by the National Center for Advancing Translational Science (NCATS), a part of the National Institutes of Health (NIH).

Challenges in Developing Drugs in the Modern Era of Cancer,
In this webinar, Don Berry describes the challenges brought by improved undertanding of cancer biology and how new trial designs can efficiently address the scientific questions these developments bring.

Clinical Trial Simulation:  The Importance of Simulating Single Trials,
Scott Berry discusses in this webinar the importance of simulating single trials.

Hierarchical Borrrowing in Personalized Medicine,
Kert Viele, Statistical Scientist for Berry Consultants, describes in this webinar how simulation can help you design enrichment studies in personalized medicine.

A Fully Bayesian World:  What a Wonderful World,
Scott Berry presents at the Royal Statistical Society's, "PSI Debate:  This house believes that pharmaceutical drug development and regulation should become fully Bayesian".

Slowly but surely, Bayesian Ideas revolutionalize medical research,
Don Berry at the 2012 International Society for Bayesian Analysis (ISBA) World Meeting in Kyoto, Japan

Bayesian Adaptive Methods for Clinical Trials,
Scott Berry, speaking from JSM 2011 (Joint Statistical Meetings), describes his new book on Bayesian methods

Adaptive Clinical Trials,
Don Berry's Webinar on Adaptive Clinical Trials for NIH

The Critical Path:  Biomarker Development & Streamlining Clinical Trials,
Don Berry's presentation at the Isaac Newton Institute for Mathematical Sciences

The Biomarkers Consortium:  I-SPY 2 Press Conference,
Don Berry speaks as part of the press conference for I-SPY 2, an innovative breast cancer clinical trial.

Adaptive Design for Clinical Trials,
Don Berry, speaking from AACR 2010 (American Association for Cancer Research), describes adaptive design for clinical trials.